• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Research

  2026-05-14

  Capsazepine stands out as a precise TRPV1 ion channel antagonist, enabling reproducible dissection of nociception and apoptosis pathways in pain and cancer research. With robust selectivity and clear workflow parameters, it empowers advanced assay design and troubleshooting beyond conventional antagonists.

• Coumestrol (SKU C5832): Reliable SERM for Cell Assays

  2026-05-14

  This article delivers scenario-driven, evidence-backed solutions for cell viability and cytotoxicity assays using Coumestrol (SKU C5832). By addressing real-world workflow challenges with data from recent literature and product specifications, we highlight how Coumestrol supports reproducible research in nuclear receptor modulation and endocrine disruption studies.

• Bay 11-7821 (BAY 11-7082): Optimizing NF-κB and Apoptosis As

  2026-05-13

  Bay 11-7821 (BAY 11-7082) empowers researchers to dissect inflammatory signaling pathways and apoptosis regulation with high reproducibility across cancer and immune models. Discover actionable protocols, troubleshooting guidance, and workflow enhancements for maximizing its utility in cell-based and in vivo studies.

• PreScission Protease: Precise HRV 3C Tag Cleavage for Protei

  2026-05-13

  PreScission Protease (PSP) leverages HRV 3C specificity for efficient, low-temperature fusion tag removal, preserving native protein function even in sensitive assays. APExBIO’s PSP streamlines workflows from chromatin studies to condensate research, offering unmatched reproducibility and yield.

• Substance P: Unifying Mechanistic Insight and Translational

  2026-05-12

  This thought-leadership article synthesizes emerging mechanistic discoveries and practical strategies for leveraging Substance P—a canonical tachykinin neuropeptide and neurokinin-1 receptor agonist—in the context of pain transmission, immune modulation, and inflammation research. By integrating evidence from both literature and advanced spectral analytics, we provide translational researchers with a roadmap for rigorous, innovative study design while addressing real-world challenges in bioaerosol interference and assay reproducibility. The discussion is grounded in the latest findings and practical recommendations, elevating the conversation beyond conventional product overviews.

• SCUBE3 Antibody Targeting Suppresses Oncogenic Signaling in

  2026-05-12

  This study identifies secretory SCUBE3 as a key driver of oncogenic signaling, therapy resistance, and immune evasion in cancer. Antibody-mediated targeting of SCUBE3 disrupts its interactions with major receptor pathways, restoring antitumor immunity and suppressing tumor progression—highlighting a novel, pan-cancer therapeutic target.

• hiPSC-Derived Intestinal Organoids Advance Pharmacokinetic S

  2026-05-11

  This study establishes a streamlined method for generating human pluripotent stem cell-derived intestinal organoids (hiPSC-IOs) with high self-renewal and differentiation potential. The resulting organoids provide a more physiologically relevant in vitro model for pharmacokinetic and drug metabolism research, addressing key limitations of existing systems.

• Eliminating Pollen Interference in EEM Fluorescence for Bioa

  2026-05-11

  Zhang et al. (2024) developed and validated a protocol to remove pollen-induced spectral interference in excitation–emission matrix (EEM) fluorescence spectroscopy, significantly improving the accuracy of hazardous bioaerosol classification. Their approach leverages advanced preprocessing, spectral transformation, and machine learning to enable robust detection of pathogens and toxins in complex environmental samples.

• AP20187 as a Chemical Inducer of Dimerization: Optimizing Co

  2026-05-10

  AP20187 empowers researchers to precisely control fusion protein dimerization, enabling tunable gene activation in living systems. Its robust solubility, high purity, and proven in vivo efficacy set it apart for conditional gene therapy and metabolic research applications.

• Dihydroartemisinin: Applied Workflows and mTOR Pathway Insig

  2026-05-09

  Dihydroartemisinin, an advanced Artemisia plant extract, empowers malaria, psoriasis, and cell signaling research with potent mTOR pathway inhibition and proven antimalarial efficacy. This guide delivers translational workflows, troubleshooting strategies, and protocol enhancements, ensuring reproducibility and high-impact results with APExBIO's high-purity compound.

• Steroid-Induced Protoplast Lysis: Mechanisms and Stabilizer

  2026-05-08

  Smith and Shay (1965) provided a mechanistic analysis of how synthetic antimicrobial steroids disrupt bacterial protoplasts, highlighting membrane destabilization over cell wall effects. Their use of stabilizers and antagonists clarified the interplay between membrane-active agents and cellular susceptibility, informing future antifungal and antimicrobial strategy designs.

• Early Pheromone Sensing Drives Adult Neurodegeneration in C.

  2026-05-08

  Peng et al. (2023) reveal that early-life pheromone exposure in C. elegans remodels neuronal development and accelerates neurodegeneration through integrated signaling pathways. This mechanistic insight links environmental chemical cues to proteostasis and adult neuronal health, with implications for modeling neurodegenerative disease.

• Imatinib Hydrochloride in Cancer Research: Protocols & Insig

  2026-05-07

  Imatinib hydrochloride (STI571 hydrochloride) is a benchmark tyrosine kinase inhibitor for dissecting oncogenic signaling in vitro and in vivo. This article provides actionable workflows, troubleshooting strategies, and translational insights—anchored in the latest dual-action kinase inhibitor research—for maximizing reproducibility and data quality in chronic myelogenous leukemia and gastrointestinal stromal tumor models.

• S63845 MCL1 Inhibitor: Advancing Mitochondrial Apoptosis Res

  2026-05-07

  This thought-leadership article examines the mechanistic foundation and translational potential of the S63845 MCL1 inhibitor. Bridging advances in mitochondrial apoptotic pathway research—including recent discoveries on LACTB-mediated mitochondrial remodeling—this analysis offers strategic guidance for researchers leveraging S63845 in hematological and solid tumor studies. The piece distinguishes itself by synthesizing cross-disciplinary insights, offering protocol guidance, and projecting the future of apoptosis modulation in cancer research.

• KR-12–Cu(II) Binding: Structure-Driven Insights for Peptide

  2026-05-06

  This study applies advanced quantum chemical modeling and experimental validation to elucidate the binding interactions between KR-12, a minimal antimicrobial peptide from human cathelicidin LL-37, and Cu(II) ions. The findings clarify the structural determinants of metal coordination, informing rational design strategies for peptide-based antimicrobials and bioconjugates.

16365 records 1/1091 page Next 12345 下5页 Last page